| License: Creative Commons Attribution 4.0 (1MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-413134
- DOI to cite this document:
- 10.5283/epub.41313
Abstract
NeuropeptideYY(1) receptors (Y1R) have been found to be overexpressed in a number of different tumours, such as breast, ovarian or renal cell cancer. In mammary carcinoma the highY(1)R density together with its high incidence of 85% in primary human breast cancers and 100% in breast cancer derived lymph node metastases attracted special attention. Therefore, the aim of this study was the ...

Owner only: item control page